Cytotoxic T cell response and expression of the target antigen in HTLV-I infection

Leukemia

Volumn 8, Issue SUPPL.1, 1994, Pages

  Kannagi, Mari ^a   Matsushita, Shuzo ^a   Shida, Hisatoshi ^b   Harada, Shinji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; HUMAN T CELL LEUKEMIA VIRUS ANTIGEN; TAX PROTEIN;

ANTIGEN EXPRESSION; CELL STIMULATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFLAMMATORY DISEASE; LEUKEMIA CELL; MONONUCLEAR CELL; NEUROLOGIC DISEASE; PLASMA FACTOR; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; VIRUS CARRIER;

EID: 0028354641     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo, RC., Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell-lymphoma. Proc. Natl. Acad. Sci. USA. 1980; 77: 7415-7419
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA. 1981; 78, 6476-6480.
3. Gessain A, Barin F, Vemant JC, Gout O, Maurs L, Calender A, De The, G. Antibodies to human T lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; ii:407-409.
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; i: 1031-1032.
5. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; ii: 1220.
6. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; i: 441-442.
7. Goudreau G, Karpati G, Carpenter S. Inflammatory myopathy in association with chronic myelopathy in HTLV-I seropositive patients. Neurology 1988; 38(Suppl. 1): 206.
8. Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vemant C, Monplaisir N. T-lymphocyte alveolitis, tropical spastic paraparesis and Sjögren syndrome. Lancet 1988; i:177.
9. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 1992; 83: 236-239.
10. Yoshida M, Osama M, Usuku K, Matsumoto M, Igata A. Viruses detected in HTLV-I associated myelopathy and adult T-cell leukemia are identical on DNA blotting. Lancet 1987; i: 1085-1086.
11. Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sagawa T, Tsuji K, Tara M, Igata A. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 1988; 23, S143-150.
12. Hill AVS, Allsopp CEM, Kwiatowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600.
13. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend ARM, McMichael AJ, Whittle HC. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434-439.
14. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H, Harada S. Target epitope in the tax protein of human T cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 1992; 66: 2928-2933.
15. Parker CE, Daenke S, Nightingale S, Bangham CRM. Activated, HTLV-I-specific cytotoxic T lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628-636.
16. Utz U, Koenig S, Coligan JE, Biddison WE. Presentation of three different viral peptides, HTLV-I tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J. Immunol. 1992; 149:214-221.
17. Elovaara I, Koenig S, Brewar AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 1993; 177:1567-1573.
18. Nagy K, Clapham P, Cheingsong-Popov R, Weiss RA. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int. J. Cancer 1983; 32:321-328.
19. Siekevitz M, Finberg MB, Holbrook N, Wong-Staal F, Green WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T cell leukemia virus, type I. Proc. Natl. Acad. Sci. USA. 1987; 84: 5389-5393.
20. X encoded by human T cell leukemia virus type I. EMBO J. 1986; 5: 2883-2888
21. Fujii M, Sassone-Corsi P, Verma IM. C-fos promotor trans activation by the tax 1 protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci, USA 1988; 85: 8526-8530.
22. Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023-1029.
23. Furukawa Y, Fujisawa J, Osame M, Tomita M, Sonoda S, Kubota R, Ijichi S, Yoshida M, Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-I-associated myelopathy (HAM/TSP). Blood 1992; 80: 1012-1016 .
24. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M, Funahashi S, Osame M, Shida H. Predominant recognition of human T cell leukemia virus type I (HTLV-I)pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 1991; 3: 761-767.
25. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245-248 (1990).
26. Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, Eiraku N, Ijichi S, Usuku K. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol. 1989; 26: 331-335.
27. Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y. Establishment of human cytotoxic T-cell lines specific for human adult T cell leukemia virus-bearing cells. J. Immunol. 1983; 130: 2942-2946.
28. Kannagi M, Matsushita S, Harada S. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell leukemia cells. Int. J. Cancer 1993; 54:582-588.
29. Mitsuya H, Matis LA, Megson M, Cohen OJ, Mann DL, Gallo RC, Broder S. Immune T cells reactive against human T-cell leukemia/lymphoma virus. Lancet 1984; i:649-652.
30. Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, De The G, Peries J, Sigaux F. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 1990; 75: 428-433.
31. Kinoshita T, Shimoyama M, Tobinai, K, Ito M, Ikeda S, Tajima K, Shimotohno J, Sugimura T. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 1989; 86: 5620-5624.
32. Saito S, Kuruki K, Ando Y, Tanigawa T, Kashimoto K, Moriyama I, Ichijo M. Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction. Jpn. J. Cancer Res. 1990; 81:890-895.
33. Mizoguchi H, O'shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Alteration in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258:1795-1798.
34. Uchiyam T, Sagawa K, Takatsuki K, Uchino H. Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differenciation. Clin. Immunol. Immunopathol. 1978; 10:24-34.
35. Powers MA, Radke K. Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late expression. J. Virol. 1992; 66:4769-4777.
36. Hoshino, H., Esumi H, Miwa M, Shimoyama M, Minato K, Tobinai K, Hirose M, Watanabe S, Inada N, Kinoshita K, Kamihira S, Ichimaru M, Sugimura T, Establishment and characterization of 10 cell lines derived from patients with adult T cell leukemia. Proc. Natl. Acad. Sci. USA 1983; 80: 6061-6065.
37. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in Adult T cell leukemia-lymphoma. Cancer Reseach (Supple.) 1985; 45: 4644s-4645s.
38. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984-87) Br. J. Haematol. 1991; 79: 428-437.
39. Kannagi M, Sugamura K, Kinoshita K, Uchino H, Hinuma Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J. Immunol. 1984; 133: 1037-1041.